Trials / Completed
CompletedNCT05713981
The Impact of Dry Eye Syndrome on Metrics of Low Contrast Vision Before and After Meibomian Gland Expression
The Impact of Dry Eye Syndrome on Novel Metrics of Low Contrast Vision Before and After Therapeutic Meibomian Gland Expression
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- University of the Incarnate Word · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The study aims to determine the impact of Meibomian Gland Dysfunction (MGD) dry eye on low contrast black/white (luminance) and cone color sensitivity performance and improvement in these functions after in-house non-invasive Meibomian gland (MG) expression.
Detailed description
This study offers possible benefits from gland expression to patients and subjects in terms of clinical measurements and care associated with meibomian gland dysfunction impacting all age ranges. Prior studies show that these interventions improve dry eye symptoms with intent to improve vision, low contrast color, and B/W vision after intervention in this study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Meibomian gland (MG) expression | The procedure is performed with a sterile cotton tip applicator once in the upper and lower eyelids of the subject's choosing. |
Timeline
- Start date
- 2023-03-01
- Primary completion
- 2023-06-08
- Completion
- 2023-06-08
- First posted
- 2023-02-06
- Last updated
- 2023-06-26
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05713981. Inclusion in this directory is not an endorsement.